Patents by Inventor Paul Von Hoegen

Paul Von Hoegen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for down-regulating ige
    Publication number: 20040156838
    Abstract: The present invention discloses methods for immunizing against autologous (self) Immunoglobulin E (IgE). In particular, the invention discloses methods for inducing cytotoxic T-lymphocytes that will specifically down-regulate B-cells producing autologous IgE, notably by means of nucleic acid vaccination or live vaccination. Also disclosed are methods for inducing antibodies reactive with autologous IgE as well as methods for inducing a combined antibody and CTK response specific for IgE. The invention also discloses specific immunogenic protein constructs, nucleic acids encoding these as well as various formulations and tools for preparing the vaccines, including vectors and transformed host cells.
    Type: Application
    Filed: March 6, 2003
    Publication date: August 12, 2004
    Inventors: Steen Klysner, Paul Von Hoegen, Bjorn Voldborg, Anand Gautam
  • Particulate complex for administering nucleic acid into a cell
    Publication number: 20030236207
    Abstract: A particulate complex including a nucleic acid and a biodegradable cationized polyhydroxylated molecule, wherein said molecule has a charge up to approximately 1.0 meq/g.
    Type: Application
    Filed: October 25, 2002
    Publication date: December 25, 2003
    Applicant: Biovector Therapeutics, S.A.
    Inventors: Arnaud Debin, Roger Kravtzoff, Marinette Moynier, Ignacio De Miguel, Olivier Balland, Philippe Pajot, Jocelyn Vaz Santiago, Paul von Hoegen
  • Method for down-regulating IgE
    Publication number: 20020172673
    Abstract: The present invention discloses methods for immunizing against autologous (self) Immunoglobulin E (IgE). In particular, the invention discloses methods for inducing cytotoxic T-lymphocytes that will specifically down-regulate B-cells producing autologous IgE, notably by means of nucleic acid vaccination or live vaccination. Also disclosed are methods for inducing antibodies reactive with autologous IgE as well as methods for inducing a combined antibody and CTK response specific for IgE. The invention also discloses specific immunogenic protein constructs, nucleic acids encoding these as well as various formulations and tools for preparing the vaccines, including vectors and transformed host cells.
    Type: Application
    Filed: September 6, 2001
    Publication date: November 21, 2002
    Applicant: Pharmexa A/S
    Inventors: Steen Klysner, Paul von Hoegen, Bjorn Voldborg, Anand Gautam
  • Particulate complex for adminstering nucleic acid into a cell
    Publication number: 20010046705
    Abstract: A particulate complex is provided comprising a particulate complex comprising a nucleic acid and a biodegradable cationized polyhydroxylated molecule, wherein the polyhydroxylated molecule has a charge up to approximately 1.0 meq/g.
    Type: Application
    Filed: December 22, 2000
    Publication date: November 29, 2001
    Inventors: Arnaud Debin, Roger Kravtzoff, Marinette Moynier, Ignacio De Miguel, Olivier Balland, Philippe Pajot, Jocelyn Vaz Santiago, Paul Von Hoegen